Literature DB >> 19882934

[Long-term observation of two cases of enhanced S-cone syndrome].

Takashi Sato1, Kazuki Kuniyoshi, Akira Nakao, Yoshikazu Shimomura, Ryota Tomemori.   

Abstract

BACKGROUND: We report two cases of enhanced S-cone syndrome (ESCS), one in a patient observed for 20 years since age 31 and the other in an elderly patient with ESCS who underwent cataract surgery. CASE REPORT: Case 1. A 31-year-old man complained of night blindness and decreased vision. At the initial visit, his corrected visual acuity was 0.7 OD and 0.3 OS. Funduscopy revealed retinal degeneration near the vascular arcade and cystic change in the macular area in both eyes. It was diagnosed as ESCS by electroretinogram (ERG) findings. During a 20-year observation, the cystic change in the macular area became ambiguous and pigmentation appeared in the retinal degeneration region, Goldmann perimetry showed remarkable constriction of I /4 isopter, and ERG showed reduction of amplitude. At age 50, his corrected visual acuity was 0.4 OD and 0.4 OS. Case 2. A 78-year-old woman complained of night blindness and decreased vision. At the initial visit, her corrected visual acuity was 0.03 OD and 0.07 OS. Advanced nuclear cataract was seen in both eyes, and funduscopy revealed retinal degeneration near the vascular arcade. It was diagnosed as ESCS by ERG findings. Cataract surgery was done in both eyes, and postoperative visual acuity was 0.3 OD and 0.2 OS, and she has maintained the same visual acuity for two years.
CONCLUSIONS: These cases indicate that retinal function of patients with ESCS decreases gradually after middle age, and that even if a cystic change in the macular area becomes ambiguous, vision does not improve. Some retinal function of ESCS patients can be maintained into old age.

Entities:  

Mesh:

Year:  2009        PMID: 19882934

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  1 in total

1.  [Peripheral fine granular retinal pigmentation in combination with macular gliosis].

Authors:  M M Nentwich; M W Ulbig
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.